Railways plans buying 25 diesel-electric locomotives

ISLAMABAD: Pakistan Railways has planned replacement of old and knackered locomotives with new 25 diesel-electric locomotives at a cost of Rs14 billion. The diesel electric locomotives will be used for various shunting points across the country.

The project for the procurement and manufacturing of 25 shunting locomotives would be implemented in three years at an estimated cost of Rs14 billion, sources in the Ministry of Railways told APP.

Currently, they said that only 51 locomotives were being operated for this service against 98 shunting points at various railway stations across the country. Additionally, most of the old locomotives would be discarded due to high maintenance costs.

They said the project was aimed at procuring and manufacturing 25 shunting diesel-electric locomotives of 2000-2200 horsepower HP to replace the overage and uneconomical locomotives.

The sources informed these old locomotives consumed excessive fuel and in most cases, high horsepower locomotives were under-utilized during shunting operations.

They said with the addition of the new locomotives would enhance the capacity of Pakistan Railways by removing the bottlenecks during the shunting of heavy load freight trains and the placement of freight loads at departure yards in Karachi, Lahore and other places.

The sources said the role of specially designed shunting locomotives was considered the backbone of train formation and train rake replacement at the platform as well as the removal of train rakes from the platform to the washing line and sick lines.

They said the locomotives were not directly involved in revenue generation but act as the supporting facilities for the placement, composition and decomposition of rolling stock.

It was pertinent to mention here that the federal government has allocated Rs 2300 million in the current Public Sector Development Programme (PSDP) to repair about 100 diesel-electric locomotives.

 

Must Read

AstraZeneca admits to covid vaccine side-effects, extends ‘sympathies’ to affectees

ASTRAZENECA, the pharmaceutical giant that became widely known during the Covid-19 pandemic, has acknowledged that its Covishield vaccine might cause uncommon side effects, such...

Epaper_24-05-1 LHR

Epaper_24-05-1 KHI